FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA granted supplemental approval for Sevelamer Carbonate from Macleods Pharmaceuticals Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)